Income Statement Bangkok Dusit Medical Services

Stocks

BDMS

TH0264A10Z04

Healthcare Facilities & Services

End-of-day quote Thailand S.E. Other stock markets 15/07/2026			5-day change	1st Jan Change
19.40 ^THB	+0.52%		+1.04%	+0.52%

24/06	Bangkok Dusit Medical Services Public Company Limited Announces Company Secretary Changes	CI
18/06	Bangkok Dusit Medical Boosts Residential Project Budget to THB29 Billion	MT

cd747facf6780e56f4ab33f1d63f4.HBW0fAvI7jLpm03WKsYY7gtkxUeXhvOJCX6BGu-j6b8.L0LtOHKr1kqw_Ce7ZLZpwzgPjTfQ9IfzTSb7WazpvtwkUo06cp7eWKDdCA

Published financial data: BANGKOK DUSIT MEDICAL SERVICES

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	7.45TCr	9.19TCr	10TCr	11TCr	11TCr
Other Revenues, Total	-	103.4Cr	125.78Cr	148.38Cr	169.91Cr
Total Revenues	7.45TCr	9.3TCr	10TCr	11TCr	11TCr
Cost of Goods Sold, Total	4.95TCr	5.83TCr	6.34TCr	6.81TCr	7.13TCr
Gross Profit	2.5TCr	3.46TCr	3.87TCr	4.13TCr	4.19TCr
Selling General & Admin Expenses, Total	1.5TCr	1.77TCr	1.98TCr	2.08TCr	2.18TCr
Other Operating Expenses, Total	1.5TCr	1.77TCr	1.98TCr	2.08TCr	2.18TCr
Operating Income	996.08Cr	1.7TCr	1.89TCr	2.05TCr	2.02TCr
Interest Expense, Total	-73Cr	-63Cr	-55Cr	-43Cr	-36Cr
Interest And Investment Income	7.77Cr	8.79Cr	22Cr	24Cr	18Cr
Net Interest Expenses	-65Cr	-54Cr	-33Cr	-20Cr	-18Cr
Income (Loss) On Equity Invest.	2.11Cr	4.18Cr	8.94Cr	7.6Cr	7.77Cr
Other Non Operating Income (Expenses)	126.26Cr	-	-	-	-
EBT, Excl. Unusual Items	1.06TCr	1.65TCr	1.87TCr	2.03TCr	2.01TCr
Gain (Loss) On Sale Of Investments	-	-	-	-	-
EBT, Incl. Unusual Items	1.06TCr	1.65TCr	1.87TCr	2.03TCr	2.01TCr
Income Tax Expense	210.34Cr	322.72Cr	375.45Cr	379.22Cr	369.42Cr
Earnings From Continuing Operations	849.04Cr	1.33TCr	1.49TCr	1.65TCr	1.64TCr
Net Income to Company	849.04Cr	1.33TCr	1.49TCr	1.65TCr	1.64TCr
Minority Interest	-55Cr	-65Cr	-52Cr	-55Cr	-52Cr
Net Income - (IS)	793.61Cr	1.26TCr	1.44TCr	1.6TCr	1.58TCr
Net Income to Common Incl Extra Items	793.61Cr	1.26TCr	1.44TCr	1.6TCr	1.58TCr
Net Income to Common Excl. Extra Items	793.61Cr	1.26TCr	1.44TCr	1.6TCr	1.58TCr
Per Share Items
Net EPS - Basic	0.5	0.79	0.9	1.01	1
Basic EPS - Continuing Operations	0.5	0.79	0.9	1.01	1
Basic Weighted Average Shares Outstanding	1.59TCr	1.59TCr	1.59TCr	1.59TCr	1.59TCr
Net EPS - Diluted	0.5	0.79	0.9	1.01	1
Diluted EPS - Continuing Operations	0.5	0.79	0.9	1.01	1
Diluted Weighted Average Shares Outstanding	1.59TCr	1.59TCr	1.59TCr	1.59TCr	1.59TCr
Normalized Basic EPS	0.38	0.61	0.7	0.76	0.76
Normalized Diluted EPS	0.38	0.61	0.7	0.76	0.76
Dividend Per Share	0.45	0.6	0.7	0.75	1
Payout Ratio	160.5	63.01	71.95	69.55	75.19
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	1.58TCr	2.25TCr	2.43TCr	2.61TCr	2.66TCr
EBITA	1.03TCr	1.73TCr	1.93TCr	2.09TCr	2.07TCr
EBIT	996.08Cr	1.7TCr	1.89TCr	2.05TCr	2.02TCr
EBITDAR	1.61TCr	2.28TCr	2.47TCr	2.66TCr	2.71TCr
Total Revenues (As Reported)	7.57TCr	9.3TCr	10TCr	11TCr	11TCr
Effective Tax Rate - (Ratio)	19.85	19.58	20.13	18.65	18.41
Total Current Taxes	218.71Cr	330.62Cr	386.86Cr	388.9Cr	386.1Cr
Total Deferred Taxes	-8.37Cr	-7.9Cr	-11Cr	-9.68Cr	-17Cr
Normalized Net Income	606.68Cr	965.28Cr	1.11TCr	1.22TCr	1.2TCr
Interest Capitalized	-	-	18Cr	19Cr	18Cr
Interest on Long-Term Debt	14Cr	13Cr	30Cr	30Cr	31Cr
Non-Cash Pension Expense	3.81Cr	6.36Cr	7.99Cr	3.98Cr	10Cr
Supplemental Operating Expense Items
Advertising Expense	50Cr	72Cr	91Cr	104.6Cr	95Cr
General and Administrative Expenses	1.5TCr	1.77TCr	1.98TCr	2.08TCr	2.18TCr
Net Rental Expense, Total	27Cr	34Cr	39Cr	46Cr	51Cr
Imputed Operating Lease Interest Expense	7.41Cr	8.01Cr	11Cr	12Cr	12Cr
Imputed Operating Lease Depreciation	20Cr	26Cr	28Cr	33Cr	39Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.09TCr	1.27TCr	779.48Cr	737.3Cr	634.16Cr
Short Term Investments	121.74Cr	180.83Cr	113Cr	131.92Cr	89Cr
Trading Asset Securities, Total	51Cr	51Cr	57Cr	2.33Cr	53.2L
Total Cash And Short Term Investments	1.27TCr	1.5TCr	949.49Cr	871.55Cr	724.19Cr
Accounts Receivable, Total	858.21Cr	997.61Cr	1.1TCr	1.16TCr	1.16TCr
Other Receivables	27Cr	27Cr	31Cr	30Cr	35Cr
Total Receivables	884.92Cr	1.02TCr	1.13TCr	1.19TCr	1.2TCr
Inventory	200.49Cr	221.13Cr	241.97Cr	260.35Cr	342.24Cr
Prepaid Expenses	28Cr	24Cr	29Cr	34Cr	-
Other Current Assets, Total	61Cr	12Cr	7.3Cr	9.45Cr	46Cr
Total Current Assets	2.44TCr	2.78TCr	2.35TCr	2.37TCr	2.31TCr
Gross Property Plant And Equipment	14TCr	15TCr	16TCr	17TCr	18TCr
Accumulated Depreciation	-5.96TCr	-6.34TCr	-6.75TCr	-6.97TCr	-7.28TCr
Net Property Plant And Equipment	8.26TCr	9.15TCr	9.73TCr	10TCr	11TCr
Long-term Investments	159.98Cr	198.16Cr	210.83Cr	246.39Cr	294.5Cr
Goodwill	1.75TCr	1.75TCr	1.75TCr	1.75TCr	1.75TCr
Other Intangibles, Total	128.9Cr	162.12Cr	183.71Cr	227.37Cr	276.37Cr
Deferred Tax Assets Long-Term	8.09Cr	7.77Cr	9.15Cr	34Cr	39Cr
Other Long-Term Assets, Total	99Cr	100Cr	117.2Cr	119.39Cr	173.09Cr
Total Assets	13TCr	14TCr	14TCr	15TCr	16TCr
Liabilities
Accounts Payable, Total	359Cr	419.73Cr	449.53Cr	493.75Cr	509.55Cr
Accrued Expenses, Total	463.23Cr	542.56Cr	590.07Cr	629.58Cr	633.31Cr
Short-term Borrowings	7.64Cr	53Cr	-	250Cr	350Cr
Current Portion of Long-Term Debt	309.99Cr	499.98Cr	250Cr	199.99Cr	299.98Cr
Current Portion of Leases	27Cr	88Cr	32Cr	32Cr	38Cr
Current Income Taxes Payable	100.58Cr	147.16Cr	160.33Cr	144.48Cr	138.11Cr
Unearned Revenue Current, Total	17Cr	18Cr	19Cr	19Cr	19Cr
Other Current Liabilities	301.91Cr	292.63Cr	342.6Cr	432.73Cr	374.95Cr
Total Current Liabilities	1.59TCr	2.06TCr	1.84TCr	2.2TCr	2.36TCr
Long-Term Debt	1.25TCr	1.05TCr	799.87Cr	599.95Cr	300Cr
Long-Term Leases	288.82Cr	668.38Cr	731.82Cr	754.03Cr	760.81Cr
Unearned Revenue Non Current	48Cr	49Cr	52Cr	46Cr	44Cr
Pension & Other Post Retirement Benefits	402.38Cr	388.65Cr	411.41Cr	498.61Cr	550.17Cr
Deferred Tax Liability Non Current	337.07Cr	392.04Cr	416.42Cr	403.36Cr	446.06Cr
Other Non Current Liabilities	156.3Cr	173.91Cr	217.87Cr	255.03Cr	331.65Cr
Total Liabilities	4.07TCr	4.78TCr	4.47TCr	4.76TCr	4.8TCr
Common Stock, Total	158.92Cr	158.92Cr	158.92Cr	158.92Cr	158.92Cr
Additional Paid In Capital	3.02TCr	3.02TCr	3.02TCr	3.02TCr	3.02TCr
Retained Earnings	4.29TCr	4.79TCr	5.2TCr	5.65TCr	6.02TCr
Comprehensive Income and Other	914.12Cr	1.02TCr	1.15TCr	1.18TCr	1.4TCr
Total Common Equity	8.38TCr	8.99TCr	9.52TCr	10TCr	11TCr
Minority Interest	391.97Cr	383.35Cr	363.02Cr	388.99Cr	411.45Cr
Total Equity	8.78TCr	9.37TCr	9.89TCr	10TCr	11TCr
Total Liabilities And Equity	13TCr	14TCr	14TCr	15TCr	16TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.59TCr	1.59TCr	1.59TCr	1.59TCr	1.59TCr
ECS Total Common Shares Outstanding	1.59TCr	1.59TCr	1.59TCr	1.59TCr	1.59TCr
Book Value / Share	5.28	5.66	5.99	6.29	6.66
Tangible Book Value	6.5TCr	7.07TCr	7.59TCr	8.02TCr	8.56TCr
Tangible Book Value Per Share	4.09	4.45	4.77	5.05	5.39
Total Debt	1.88TCr	2.36TCr	1.81TCr	1.84TCr	1.75TCr
Net Debt	616.92Cr	860.63Cr	863.91Cr	964.24Cr	1.02TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	357.33Cr	352.59Cr	370.15Cr	445.54Cr	487.35Cr
Debt Equivalent Oper. Leases	219.2Cr	268.8Cr	312.8Cr	366.4Cr	410.4Cr
Minority Interest, Total (Incl. Fin. Div)	391.97Cr	383.35Cr	363.02Cr	388.99Cr	411.45Cr
Equity Method Investments, Total	93Cr	96Cr	103.87Cr	108.92Cr	128.86Cr
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	13Cr	12Cr	18Cr	22Cr	26Cr
Inventories - Finished Goods, Total	192.62Cr	216.92Cr	230.46Cr	245.71Cr	326.32Cr
Inventories - Others	-	-	-	-	-
Land - (BS)	4.04TCr	4.36TCr	4.61TCr	4.72TCr	5.02TCr
Buildings, Total	5TCr	5.17TCr	5.39TCr	5.6TCr	6.03TCr
Machinery, Total	4.63TCr	4.78TCr	5.07TCr	5.41TCr	5.8TCr
Full Time Employees	-	-	-	-	-
Part Time Employees	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	53Cr	55Cr	51Cr	49Cr	47Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	793.61Cr	1.26TCr	1.44TCr	1.6TCr	1.58TCr
Depreciation & Amortization - CF	601.15Cr	561.91Cr	547.12Cr	571.05Cr	635.25Cr
Amortization of Goodwill and Intangible Assets - (CF)	31Cr	33Cr	38Cr	42Cr	50Cr
Depreciation & Amortization, Total	632.13Cr	594.96Cr	584.8Cr	613.17Cr	684.82Cr
Amortization of Deferred Charges, Total - (CF)	21.63L	16.44L	10.25L	7L	5L
(Gain) Loss From Sale Of Asset	57.71L	-15.98L	-52.66L	-2.65Cr	2.09Cr
(Gain) Loss on Sale of Investments - (CF)	3.75Cr	9.3Cr	-51.68L	48.86L	72.63L
Asset Writedown & Restructuring Costs	27Cr	2.43Cr	4.21Cr	2.59Cr	9.47Cr
(Income) Loss On Equity Investments - (CF)	-2.11Cr	-4.18Cr	-8.94Cr	-7.6Cr	-7.77Cr
Provision and Write-off of Bad Debts	17Cr	20Cr	18Cr	19Cr	19Cr
Other Operating Activities, Total	19Cr	157.82Cr	121.54Cr	95Cr	137.96Cr
Change In Accounts Receivable	-211.09Cr	-152.53Cr	-124.2Cr	-88Cr	-26Cr
Change In Inventories	-17Cr	-34Cr	-24Cr	-21Cr	-32Cr
Change In Accounts Payable	69Cr	93Cr	13Cr	44Cr	5.92Cr
Change in Unearned Revenues	17Cr	27Cr	30Cr	20Cr	24Cr
Change in Other Net Operating Assets	107.53Cr	52Cr	27Cr	22Cr	-67Cr
Cash from Operations	1.46TCr	2.03TCr	2.08TCr	2.3TCr	2.34TCr
Capital Expenditure	-397.54Cr	-440.58Cr	-774.56Cr	-1.07TCr	-1.04TCr
Sale of Property, Plant, and Equipment	3.74Cr	3.58Cr	2.35Cr	7.82Cr	41Cr
Cash Acquisitions	2.14Cr	-	-	-	-
Sale (Purchase) of Real Estate properties	-25T	-	-3L	-5.11Cr	-2.79Cr
Sale (Purchase) of Intangible assets	-40Cr	-67Cr	-56Cr	-95Cr	-92Cr
Investment in Marketable and Equity Securities, Total	-47Cr	-88Cr	63Cr	18Cr	24Cr
Other Investing Activities, Total	2.23Cr	1.66Cr	-11Cr	8.99Cr	9.43Cr
Cash from Investing	-476.31Cr	-590.14Cr	-775.42Cr	-1.14TCr	-1.06TCr
Short Term Debt Issued, Total	-	50Cr	-	250Cr	100Cr
Long-Term Debt Issued, Total	-	300Cr	-	-	-
Total Debt Issued	-	350Cr	-	250Cr	100Cr
Short Term Debt Repaid, Total	-62L	-4.44Cr	-53Cr	-	-
Long-Term Debt Repaid, Total	-559.98Cr	-610.63Cr	-633.53Cr	-305.83Cr	-245.92Cr
Total Debt Repaid	-560.6Cr	-615.07Cr	-686.73Cr	-305.83Cr	-245.92Cr
Common Dividends Paid	-1.27TCr	-794.34Cr	-1.03TCr	-1.11TCr	-1.19TCr
Common & Preferred Stock Dividends Paid	-1.27TCr	-794.34Cr	-1.03TCr	-1.11TCr	-1.19TCr
Other Financing Activities, Total	-19Cr	-203.66Cr	-69Cr	-29Cr	-35Cr
Cash from Financing	-1.85TCr	-1.26TCr	-1.79TCr	-1.2TCr	-1.37TCr
Foreign Exchange Rate Adjustments	-	-	-	-2.51Cr	-5.33Cr
Net Change in Cash	-873.27Cr	173.44Cr	-487.32Cr	-42Cr	-103.14Cr
Supplemental Items
Cash Interest Paid	59Cr	48Cr	48Cr	34Cr	24Cr
Cash Income Tax Paid (Refund)	303.95Cr	288.04Cr	373.45Cr	402.1Cr	386.25Cr
Levered Free Cash Flow	676.88Cr	1.18TCr	918.15Cr	764.88Cr	652.69Cr
Unlevered Free Cash Flow	722.19Cr	1.22TCr	952.21Cr	791.9Cr	674.92Cr
Change In Net Working Capital	95Cr	-72Cr	-17Cr	-69Cr	136.84Cr
Net Debt Issued / Repaid	-560.6Cr	-265.07Cr	-686.73Cr	-56Cr	-145.92Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	4.71	7.86	8.28	8.66	8.14
Return on Total Capital	5.6	9.48	10.08	10.67	10.09
Return On Equity %	9.47	14.61	15.47	16.29	15.3
Return on Common Equity	9.24	14.51	15.53	16.36	15.39
Margin Analysis
Gross Profit Margin %	33.56	37.26	37.9	37.75	37.05
SG&A Margin	20.19	18.99	19.4	19.05	19.24
EBITDA Margin %	21.24	24.21	23.83	23.91	23.46
EBITA Margin %	13.8	18.62	18.87	19.09	18.25
EBIT Margin %	13.38	18.27	18.5	18.7	17.81
Income From Continuing Operations Margin %	11.4	14.26	14.59	15.12	14.46
Net Income Margin %	10.66	13.56	14.08	14.62	14
Net Avail. For Common Margin %	10.66	13.56	14.08	14.62	14
Normalized Net Income Margin	8.15	10.38	10.91	11.12	10.62
Levered Free Cash Flow Margin	9.09	12.71	8.99	6.99	5.77
Unlevered Free Cash Flow Margin	9.7	13.13	9.33	7.24	5.96
Asset Turnover
Asset Turnover	0.56	0.69	0.72	0.74	0.73
Fixed Assets Turnover	0.89	1.07	1.08	1.09	1.06
Receivables Turnover (Average Receivables)	9.75	9.91	9.64	9.56	9.59
Inventory Turnover (Average Inventory)	25.63	27.67	27.39	27.1	23.65
Short Term Liquidity
Current Ratio	1.54	1.35	1.28	1.07	0.98
Quick Ratio	1.36	1.22	1.13	0.94	0.81
Operating Cash Flow to Current Liabilities	0.92	0.98	1.13	1.04	0.99
Days Sales Outstanding (Average Receivables)	37.45	36.84	37.87	38.28	38.05
Days Outstanding Inventory (Average Inventory)	14.24	13.19	13.33	13.5	15.43
Average Days Payable Outstanding	24.52	24.28	24.94	25.29	25.4
Cash Conversion Cycle (Average Days)	27.17	25.75	26.27	26.49	28.08
Long Term Solvency
Total Debt/Equity	21.45	25.18	18.34	17.66	15.9
Total Debt / Total Capital	17.66	20.11	15.5	15.01	13.72
LT Debt/Equity	17.53	18.33	15.49	13.03	9.64
Long-Term Debt / Total Capital	14.43	14.65	13.09	11.07	8.32
Total Liabilities / Total Assets	31.68	33.79	31.15	31.41	30.36
EBIT / Interest Expense	13.67	26.87	34.56	47.19	56.55
EBITDA / Interest Expense	22.35	36.28	45.26	61.34	75.75
(EBITDA - Capex) / Interest Expense	16.89	29.31	31.09	36.58	46.54
Total Debt / EBITDA	1.16	1.03	0.73	0.69	0.65
Net Debt / EBITDA	0.38	0.38	0.35	0.36	0.38
Total Debt / (EBITDA - Capex)	1.53	1.27	1.07	1.16	1.05
Net Debt / (EBITDA - Capex)	0.5	0.46	0.51	0.61	0.62
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	9.37	22.79	9.83	7.09	3.53
Gross Profit, 1 Yr. Growth %	15.14	32.12	11.72	6.67	1.61
EBITDA, 1 Yr. Growth %	17.13	31.86	8.11	7.41	1.58
EBITA, 1 Yr. Growth %	31.05	50.13	11.29	8.33	-1.03
EBIT, 1 Yr. Growth %	32.07	51.32	11.24	8.26	-1.42
Earnings From Cont. Operations, 1 Yr. Growth %	11	56.11	12.4	11.15	-1.03
Net Income, 1 Yr. Growth %	10.01	58.85	14.03	11.35	-0.87
Normalized Net Income, 1 Yr. Growth %	33.42	59.11	15.36	9.16	-1.12
Diluted EPS Before Extra, 1 Yr. Growth %	10.01	58.85	14.03	11.35	-0.87
Accounts Receivable, 1 Yr. Growth %	28.17	16.24	9.79	6.01	0.23
Inventory, 1 Yr. Growth %	8.07	10.29	9.43	7.59	31.46
Net Property, Plant and Equip., 1 Yr. Growth %	-2.45	10.87	6.31	6.93	5.22
Total Assets, 1 Yr. Growth %	-5.58	10.19	1.45	5.37	4.26
Tangible Book Value, 1 Yr. Growth %	-5.79	8.77	7.28	5.47	6.69
Common Equity, 1 Yr. Growth %	-4.62	7.2	5.97	4.81	5.86
Cash From Operations, 1 Yr. Growth %	24.65	39.18	2.53	10.19	1.73
Capital Expenditures, 1 Yr. Growth %	-37.25	10.83	75.8	38.53	-2.92
Levered Free Cash Flow, 1 Yr. Growth %	190.31	56.33	-22.29	-16.69	-14.67
Unlevered Free Cash Flow, 1 Yr. Growth %	151.33	52.4	-22.01	-16.84	-14.77
Dividend Per Share, 1 Yr. Growth %	-18.18	33.33	16.67	7.14	33.33
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-5.13	16.86	16.13	8.45	5.29
Gross Profit, 2 Yr. CAGR %	-6.27	26.33	21.49	9.17	4.11
EBITDA, 2 Yr. CAGR %	-2.85	29.14	19.39	7.76	4.46
EBITA, 2 Yr. CAGR %	-4.51	48.64	29.26	9.8	3.54
EBIT, 2 Yr. CAGR %	-4.84	50.06	29.74	9.74	3.31
Earnings From Cont. Operations, 2 Yr. CAGR %	-27.18	31.63	32.46	11.71	4.88
Net Income, 2 Yr. CAGR %	-28.49	32.19	34.59	12.61	5.06
Normalized Net Income, 2 Yr. CAGR %	-8.03	45.7	35.48	12.21	3.89
Diluted EPS Before Extra, 2 Yr. CAGR %	-28.82	32.19	34.59	12.61	5.06
Accounts Receivable, 2 Yr. CAGR %	1.69	22.06	12.97	7.88	3.08
Inventory, 2 Yr. CAGR %	4.29	9.18	9.86	8.51	18.93
Net Property, Plant and Equip., 2 Yr. CAGR %	2.59	4	8.57	6.62	6.07
Total Assets, 2 Yr. CAGR %	-1.97	2	5.73	3.46	4.81
Tangible Book Value, 2 Yr. CAGR %	0.86	1.23	8.02	6.51	6.08
Common Equity, 2 Yr. CAGR %	0.02	1.11	6.58	5.5	5.33
Cash From Operations, 2 Yr. CAGR %	0.05	31.72	19.46	6.43	5.88
Capital Expenditures, 2 Yr. CAGR %	-26.89	-16.61	39.59	56.06	15.97
Levered Free Cash Flow, 2 Yr. CAGR %	42.22	125.12	10.22	-19.54	-15.69
Unlevered Free Cash Flow, 2 Yr. CAGR %	35.85	106.13	9.02	-19.46	-15.81
Dividend Per Share, 2 Yr. CAGR %	-9.55	4.45	24.72	11.8	19.52
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-1.27	3.97	14.47	13.04	6.79
Gross Profit, 3 Yr. CAGR %	-2.39	6.79	21.26	16.34	6.59
EBITDA, 3 Yr. CAGR %	-0.93	10.35	21.71	15.26	5.66
EBITA, 3 Yr. CAGR %	-2.73	15.41	34.97	21.87	6.06
EBIT, 3 Yr. CAGR %	-2.88	15.58	35.81	22.14	5.88
Earnings From Cont. Operations, 3 Yr. CAGR %	-4.17	-6.1	24.88	24.89	7.29
Net Income, 3 Yr. CAGR %	-4.78	-6.69	25.84	26.3	7.93
Normalized Net Income, 3 Yr. CAGR %	-5.92	10.41	34.79	26.07	7.58
Diluted EPS Before Extra, 3 Yr. CAGR %	-5.42	-6.98	25.84	26.3	7.93
Accounts Receivable, 3 Yr. CAGR %	6.72	6.33	17.83	10.6	5.27
Inventory, 3 Yr. CAGR %	3.93	6.25	9.26	9.1	15.67
Net Property, Plant and Equip., 3 Yr. CAGR %	3.46	5.28	4.76	8.02	6.15
Total Assets, 3 Yr. CAGR %	-1.28	1.93	1.82	5.66	3.73
Tangible Book Value, 3 Yr. CAGR %	8.71	3.43	3.2	7.26	6.57
Common Equity, 3 Yr. CAGR %	6.04	2.36	2.71	6.06	5.62
Cash From Operations, 3 Yr. CAGR %	-0.55	11.69	21.16	16.39	4.84
Capital Expenditures, 3 Yr. CAGR %	-17.65	-16.01	6.93	39.23	33.22
Levered Free Cash Flow, 3 Yr. CAGR %	13.15	52.27	57.92	0.4	-17.95
Unlevered Free Cash Flow, 3 Yr. CAGR %	10.34	46.12	49.09	-0.38	-17.93
Dividend Per Share, 3 Yr. CAGR %	12.04	2.94	8.37	18.56	18.56
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.86	5.02	5.71	5.74	10.71
Gross Profit, 5 Yr. CAGR %	2.01	6.91	7.57	7.73	14.09
EBITDA, 5 Yr. CAGR %	2.78	7.78	8.4	9.31	14.49
EBITA, 5 Yr. CAGR %	2.2	10.37	11.54	13.13	21.39
EBIT, 5 Yr. CAGR %	2.09	10.5	11.68	13.21	21.73
Earnings From Cont. Operations, 5 Yr. CAGR %	-0.65	4.62	9.08	0.65	16.43
Net Income, 5 Yr. CAGR %	-1.1	4.29	9.36	0.6	17.05
Normalized Net Income, 5 Yr. CAGR %	-0.33	9.79	8.85	11.13	21.46
Diluted EPS Before Extra, 5 Yr. CAGR %	-1.6	3.76	8.91	0.41	17.05
Accounts Receivable, 5 Yr. CAGR %	8.33	9.19	9.18	6.95	11.69
Inventory, 5 Yr. CAGR %	5.75	4.97	6.26	7.15	13.03
Net Property, Plant and Equip., 5 Yr. CAGR %	7.89	5.05	5.47	5.81	5.28
Total Assets, 5 Yr. CAGR %	3.72	2.91	1.47	2.54	3.03
Tangible Book Value, 5 Yr. CAGR %	12	10.14	8.43	4.65	4.4
Common Equity, 5 Yr. CAGR %	8.52	7.34	6.26	3.6	3.79
Cash From Operations, 5 Yr. CAGR %	3.19	13.14	7.02	9.56	14.86
Capital Expenditures, 5 Yr. CAGR %	-14.11	-22.04	1.7	7.61	10.46
Levered Free Cash Flow, 5 Yr. CAGR %	58.67	14.78	14.46	17.98	22.86
Unlevered Free Cash Flow, 5 Yr. CAGR %	43.38	19.47	12.11	15.14	18.62
Dividend Per Share, 5 Yr. CAGR %	9.18	10.76	16.95	6.4	12.7